EGM
TARS icon

Engineers Gate Manager’s Tarsus Pharmaceuticals TARS Stock Holding History

Engineers Gate Manager’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299K Buy
4,755
+1,900
+67% +$121K ﹤0.01% 1787
2026
Q1 		$200K Sell
2,855
-18,146
-86% -$1.27M ﹤0.01% 1906
2025
Q4 		$1.72M Buy
21,001
+14,621
+229% +$1.09M 0.02% 768
2025
Q3 		$379K Sell
6,380
-6,435
-50% -$317K ﹤0.01% 1641
2025
Q2 		$519K Buy
12,815
+6,088
+91% +$274K 0.01% 1464
2025
Q1 		$346K Buy
+6,727
New +$333K 0.01% 1629
2024
Q3 		– Sell
-11,347
Closed -$308K – 2393
2024
Q2 		$308K Buy
+11,347
New +$382K 0.01% 1451

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Engineers Gate Manager's TARS Position: Q2 2026 in Review

Engineers Gate Manager increased its Tarsus Pharmaceuticals (TARS) stake by 67% in Q2 2026, buying an estimated $121K and bringing the position to 4,755 shares worth $299K. The position accounts for ﹤0.01% of the portfolio, ranked #1787.

Engineers Gate Manager first reported a position in TARS in Q2 2024 and has held it in 7 quarters since. The position peaked at $1.72M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Engineers Gate Manager held 4,755 shares of Tarsus Pharmaceuticals worth $299K as of Q2 2026.
  • Engineers Gate Manager bought 1,900 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $121K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1787 holding.
  • Engineers Gate Manager first reported a position in Tarsus Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • Engineers Gate Manager's Tarsus Pharmaceuticals position peaked at $1.72M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.